Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia
Background and aims: Heterozygous familial hypercholesterolemia (HeFH) is increasingly better diagnosed and treatments can improve the cardiovascular prognosis. We evaluated the long-term cardiovascular risk of HeFH using the French REgistry of Familial hypERCHOLesterolemia (REFERCHOL). Methods: We...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Atherosclerosis Plus |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667089522000451 |